Marie‐France Moreau

Author

Marie‐France Moreau

Also Known As

A. Moreau, M F Moreau, M MOREAU, M Moreau, M. F. Moreau, M. Moreau, M.-F. Moreau, M.F. Moreau, M.‐F. MOREAU, Marie-France Moreau

Publications

940

Citations

H-Index

Concepts

All Affiliations

Inserm Université Clermont Auvergne Centre Jean Perrin Cisbio (France)Clermont Université

About

Marie‐France Moreau is an author at Inserm specializing in medicine, engineering, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	529
2	Engineering	11	11	500
3	Health Sciences	4	4	97
4	Natural Sciences	2	2	29
5	Allergy	1	1	20

Marie‐France Moreau

Publications

795

Citations

H-Index

Page 1

	Year	Citations
Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide). J. Michelot, Marie‐France Moreau, A. Veyre, PubMed Primary MelanomasSurgical OncologyEngineeringMedicineMelanoma	1993	119
Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma. J. Michelot, Marie‐France Moreau, P.G. Labarre, PubMed EngineeringMalignant MelanomaNew Iodine-125 RadiopharmaceuticalsTumor UptakeTheranostics	1991	89
123 I- N -(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging Nicole Moins, M. D’Incan, J. Bonafous, European Journal of Nuclear Medicine and Molecular Imaging Potential Imaging AgentI- NEngineeringMedicineImaging Agent	2002	72
Detection of Simian Immunodeficiency Virus in Semen, Urethra, and Male Reproductive Organs during Efficient Highly Active Antiretroviral Therapy Giulia Matusali, N Dereuddre-Bosquet, Anna Le Tortorec, Journal of Virology	2015	53
Synthesis, characterization and comparative biodistribution study of a new series of p -Iodine-125 benzamides as potential melanoma imaging agents Nicole Moins, Janine Papon, Hélène Seguin, Nuclear Medicine and Biology Medicinal ChemistryEngineeringP -Iodine-125 BenzamidesPotential MelanomaMedicine	2001	49
Synthesis, radiolabeling, and preliminary evaluation in mice of some (N-Diethylaminoethyl)-4-iodobenzamide derivatives as melanoma imaging agents Marie‐France Moreau, J. Michelot, Janine Papon, Nuclear Medicine and Biology EngineeringPreliminary EvaluationMedicineImaging AgentMelanoma	1995	43
Biodistribution of dual radiolabeled lipidic nanocapsules in the rat using scintigraphy and γ counting A Cahouet, B. Denizot, François Hindré, International Journal of Pharmaceutics NanomedicineLipidic NanocapsulesNanotherapeuticsEngineeringγ Counting	2002	41
Melanin affinity of N-(2-diethylaminoethyl)-4-iodobenzamide, an effective melanoma imaging agent P. Labarre, Janine Papon, Marie‐France Moreau, Melanoma Research	2002	36
Secondary ion mass spectrometry as a tool for investigating radiopharmaceutical distribution at the cellular level: the example of I-BZA and (14)C-I-BZA. Féras Chéhadé, Claire de Labriolle-Vaylet, Nicole Moins, PubMed	2005	30
Evaluation in mice of some iodinated melanoma imaging agents using cryosectioning and multi-wire proportional counting P. Labarre, Janine Papon, Marie‐France Moreau, European Journal of Nuclear Medicine and Molecular Imaging Multi-wire Proportional CountingEngineeringMelanomaBiomedical ImagingTheranostics	1999	29

Page 1